MedPath

DACARBAZINE FOR INJECTION BP

DACARBAZINE FOR INJECTION BP

Approved
DIN Number

02241445

Drug Class

Human

Market Date

Apr 4, 2000

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02241445
AIG Number0111126003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01AX04 DACARBAZINE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DACARBAZINEActive
Strength: 600 MG / VIAL
Monograph: DACARBAZINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.